Skip to main content
. 2021 Feb 4;22(4):1561. doi: 10.3390/ijms22041561

Figure 1.

Figure 1

Conceptual visualization of therapeutic approach with an impact across a human body. In the hunt for HD biomarkers able to measure an outcome of treatment, one might choose from a whole spectrum of analytes ranging from CNS, through PNS, peripheral organs and blood, ending up in motoric skills of HD patients.